INTRODUCTION
Renal vein thrombosis (RVT) is a rare, but serious cause of graft loss in kidney transplant recipients (KTRs) (1) . The incidence of RVT after kidney transplantation (KT) is 0.4% ∼6%, and most cases occur as an acute event within 2 weeks after KT (2) . Most causes of RVT are surgical complications such as compression of the renal vein by hematoma or lymphocele, kinking in the renal vein, and stenosis of the anastomosis site(3). However, late-onset RVT is very rare and can also be associated with underlying disorders such as glomerulonephritis(4), immunosuppressive therapy(5), a hypercoagulable state(6), or extension of iliofemoral deep venous thrombosis (7) . Typical clinical presentation of RVT includes sudden onset of oliguria, hematuria, deterioration of allograft function, and a painful, tender, and swollen allograft (8) .
We report a case with sudden development of very late-onset RVT after KT.
CASE REPORT
A 32-year-old man was diagnosed with focal segmental glomerulosclerosis due to severe proteinuria. He progressed to end-stage renal disease after 2 years and was started on thrice weekly hemodialysis. He underwent deceased donor KT. We used antithymocyte globulin (ATG) for induction, and tacrolimus, mycophenolate mofetil, and prednisolone for maintenance. Focal segmental glomerulonephritis recurred within a day after KT. He received plasmapheresis nine times in 14 days, and a single dose of rituximab (375 mg/m 2 ). Three weeks after KT, he was discharged with a serum creatinine level of 0.98 mg/dL. However, he required intravenous supplementation of albumin twice a week be- RVT is diagnosed with Doppler ultrasound; the sonographic image shows absence of venous blood flow with diastolic arterial flow reversal (14) . In this case, Doppler ultrasound showed an absence of venous flow in the transplanted kidney. MRI was performed for more precise diagnosis, and showed thrombosis from the allograft kidney vein to the anastomosis site of the left common iliac vein and a swollen allograft kidney.
As prompt intervention is needed to avoid irreversible graft loss, RVT is often treated with medical thrombolytics or mechanical thrombectomy. In this case, we used unfractionated heparin and warfarin, without thrombolytics and mechanical thrombectomy. Allograft function normalized and thrombosis disappeared after 3 months of treatment.
In conclusion, late-onset RVT in KTR is rare and the risk is higher with recurrent glomerulonephritis. Careful monitoring for risk factors of RVT is required; early detection through strong clinical suspicion and prompt treatment are very important to restore renal allograft function.
